Cell Impact Ab Stock Short Ratio
| CI Stock | 0.17 0.01 5.56% |
Cell Impact AB fundamentals help investors to digest information that contributes to Cell Impact's financial success or failures. It also enables traders to predict the movement of Cell Stock. The fundamental analysis module provides a way to measure Cell Impact's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cell Impact stock.
Cell |
Cell Impact AB Company Short Ratio Analysis
Cell Impact's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Cell Impact AB has a Short Ratio of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Short Ratio (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Cell Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.2 | |||
| Profit Margin | (1.22) % | |||
| Operating Margin | (1.19) % | |||
| Current Valuation | 821.62 M | |||
| Shares Outstanding | 75.83 M | |||
| Shares Owned By Insiders | 17.07 % | |||
| Shares Owned By Institutions | 13.68 % | |||
| Price To Book | 2.79 X | |||
| Price To Sales | 11.09 X | |||
| Revenue | 71.35 M | |||
| Gross Profit | 34.88 M | |||
| EBITDA | (67.85 M) | |||
| Net Income | (79.85 M) | |||
| Book Value Per Share | 4.66 X | |||
| Cash Flow From Operations | (86.08 M) | |||
| Earnings Per Share | (1.41) X | |||
| Number Of Employees | 113 | |||
| Beta | 1.46 | |||
| Market Capitalization | 912.57 M | |||
| Total Asset | 238.72 M | |||
| Net Asset | 238.72 M |
About Cell Impact Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cell Impact AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cell Impact using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cell Impact AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cell Stock Analysis
When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.